A collaborative study of an alternative in vitro potency assay for the Japanese encephalitis vaccine
- 1 September 2016
- journal article
- Published by Elsevier in Virus Research
- Vol. 223, 190-196
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Food and Drug Safety (MFDS) (11171MFDS352)
This publication has 20 references indexed in Scilit:
- International regulatory requirements for vaccine safety and potency testing: a WHO perspective&Procedia in Vaccinology, 2011
- Alternative methods and strategies to reduce, refine, and replace animal use for human vaccine post-licensing safety testing: state of the science and future directionsProcedia in Vaccinology, 2011
- The consistency approach for quality control of vaccines – A strategy to improve quality control and implement 3RsBiologicals, 2011
- Overview: Japanese encephalitisProgress in Neurobiology, 2010
- Stability of Freeze-dried Inactivated Japanese Encephalitis Vaccine under Different Experimental ConditionsAmerican Journal of Biomedical Sciences, 2010
- Would an in vitro ELISA test be a suitable alternative potency method to the in vivo immunogenicity assay commonly used in the context of international Hepatitis A vaccines batch release?Vaccine, 2010
- Does antiviral therapy have a role in the control of Japanese encephalitis?Antiviral Research, 2007
- Accuracy and repeatability of a micro plaque reduction neutralization test for vaccinia antibodiesBiologicals, 2007
- Evaluation of the potency of BIKEN inactivated Japanese Encephalitis vaccine and DNA vaccines in an intracerebral Japanese Encephalitis virus challenge modelVaccine, 2000
- Antigenicity of Japanese encephalitis virus envelope glycoprotein V 3 (E) and its cyanogen bromide cleaved fragments examined by monoclonal antibodies and Western blottingArchives of Virology, 1987